Pediatric and adult renal tumors are typically, angiogenic, invasive and potentially metatastic. Morbidity and mortality associated with Wilm's tumor is usually associated with metastases. Recently, the lysophospholipid, sphingosine-1-phosphate (S1P), and its associated G-protein-coupled receptors have emerged as putative regulators of angiogenesis, tumor proliferation, migration and metastasis. S1P receptor isotypic expression may be a determinant of tumor cell migration. We propose to gain mechanistic insights into the role of S1P receptor signaling in Wilm's tumor cells.
In Aim 1 the expression of S1P receptors and S1P metabolizing enzymes in Wilm's tumor cell lines and clinical specimens will be evaluated using quantitative RT-PCR, western blot analysis, and immunohistochemical techniques.
In Aim 2 the mechanisms of S1P signaling will be studied by S1P receptor overexpression and RNA interference. Cell lines that overexpress key SIP-metabolizing enzyme will be used to assess cell behavior in response to changes in S1P. S1P-receptor coupling to G proteins (Gi, GS, Gq and G12/13) and subsequent activation of Rho family GTPases (Rho, Rac, Cdc42) and Rho kinases have been implicated in S1P regulation of tumor cell motility. We will study the importance of these pathways and of the effectors downstream from Rho kinase, such as LIM-kinase (LIMK) and cofilin, by studying Rho and Rac activation, inhibition of Rho kinase, and the phosphorylation status of LIMK and cofilin.
In Aim 3 growth, invasion and metastasis of naive cell lines and of S1P receptor-modified Wilm's cell lines in an established nude mouse model will be studied, thereby confirming and validating our ex vivo and in vitro results. Renal cell carcinoma cell lines from adult patients will be used for comparison. The results of these studies will contribute to our understanding of the processes of Wilm's tumor migration/metastasis and may offer novel therapeutic approaches for renal tumors.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08DK070468-05
Application #
7687991
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Rankin, Tracy L
Project Start
2005-09-23
Project End
2011-08-31
Budget Start
2009-09-01
Budget End
2011-08-31
Support Year
5
Fiscal Year
2009
Total Cost
$124,630
Indirect Cost
Name
Connecticut Children's Medical Center
Department
Type
DUNS #
077314268
City
Hartford
State
CT
Country
United States
Zip Code
06106
Li, Mei-Hong; Hla, Timothy; Ferrer, Fernando (2011) Sphingolipid modulation of angiogenic factor expression in neuroblastoma. Cancer Prev Res (Phila) 4:1325-32
Li, Mei-Hong; Yamase, Harold; Ferrer, Fernando (2010) Characterization of a WiT49 cell line derived orthotopic model of Wilms tumor. Pediatr Blood Cancer 54:316-8
Li, Mei-Hong; Sanchez, Teresa; Milne, Ginger L et al. (2009) S1P/S1P2 signaling induces cyclooxygenase-2 expression in Wilms tumor. J Urol 181:1347-52
Li, Mei-Hong; Sanchez, Teresa; Yamase, Harold et al. (2009) S1P/S1P1 signaling stimulates cell migration and invasion in Wilms tumor. Cancer Lett 276:171-9
Li, Mei-Hong; Sanchez, Teresa; Pappalardo, Anna et al. (2008) Induction of antiproliferative connective tissue growth factor expression in Wilms'tumor cells by sphingosine-1-phosphate receptor 2. Mol Cancer Res 6:1649-56